ResearcherHokkaido UniversityActive in the last 2 years
Shota Kuwabara
Matched on ORCID iD 0000-0002-7569-1403; OpenAlex author ID A5033210375. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 4
- Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort stu… Co-author DOI 10.1186/s12893-024-02395-2↗
- Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9. Co-author DOI 10.1245/s10434-022-11630-0↗
- Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14023↗
- Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. Co-author DOI 10.18632/oncotarget.21939↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Satoshi Hirano · 4 shared papers, 2017–2024 · strength 0.45
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Osamu Sato · 3 shared papers, 2017–2024 · strength 0.34
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Takahiro Tsuchikawa · 3 shared papers, 2017–2022 · strength 0.24
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Toru Nakamura · 3 shared papers, 2017–2022 · strength 0.24
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Masato Ono · 3 shared papers, 2017–2022 · strength 0.24
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Yuma Aoki · 1 shared paper, 2024 · strength 0.21
- Yuta Takeuchi · 1 shared paper, 2024 · strength 0.21
- Toshiaki Shichinohe · 2 shared papers, 2019–2022 · strength 0.19
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Yoshitsugu Nakanishi · 2 shared papers, 2019–2022 · strength 0.19
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Toshimichi Asano · 2 shared papers, 2019–2022 · strength 0.19
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Yuko Omori · 1 shared paper, 2022 · strength 0.11
- Yusuke Mizukami · 1 shared paper, 2022 · strength 0.11
- Toru Furukawa · 1 shared paper, 2022 · strength 0.11
- Yuma Hane · 1 shared paper, 2019 · strength 0.07
- Hironobu Takano · 1 shared paper, 2017 · strength 0.05
- Shoki Sato · 1 shared paper, 2017 · strength 0.05
- Kazuho Inoko · 1 shared paper, 2017 · strength 0.05
- Shintaro Takeuchi · 1 shared paper, 2017 · strength 0.05
- Toshihiro Kushibiki · 1 shared paper, 2017 · strength 0.05
- Yusuke Nakamura · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.